Patents Assigned to Sensco Technologies, Inc. - Justia Patents Search

Patents Assigned to Sensco Technologies, Inc.

Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye

Patent number: 7381708

Abstract: The present invention provides methods for preventing retinal ganglion cell death in the glaucomatous eye and methods for suppressing apoptosis-specific eIF5A1 expression through the use of antisense oligonucleotides targeted to human apoptosis-specific eIF5A1.

Type: Grant

Filed: March 10, 2003

Date of Patent: June 3, 2008

Assignee: Sensco Technologies, Inc.

Inventors: Catherine Taylor, Dominic Cliché, Elizabeth Margaret Heikkila, Diane Michelle Senchyna, John Gerard Flanagan, John E. Thompson